CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells
Archana Bommi‐Reddy(Morpho (United States)), Andrew R. Conery(Intarcia Therapeutics (United States))
Cited by 18
Related Papers
Control of Cyclin D1 and Breast Tumorigenesis by the EglN2 Prolyl Hydroxylase
|Cancer Cell|2009|142